Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06775730 · ClinicalTrials.gov registry record · Phase 1
A Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants
A Phase 1 study of Healthy Adult Female Participants, sponsored by Shionogi.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06775730 is a Phase 1 study of Healthy Adult Female Participants that has completed, run by Shionogi. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06775730, a Phase 1 study of Healthy Adult Female Participants, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the potential for drug-drug interactions.
Conditions Studied
Interventions
- DRUG Ensitrelvir
Study Locations (1)
California
- Early Phase Clinical Unit Los Angeles - Glendale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-12-30 |
| Est. Completion | 2025-04-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06775730
The ClinicalTrials.gov registry entry for NCT06775730 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Adult Female Participants appearing as the primary indexed condition, and to 1 intervention - of which Ensitrelvir is the first listed.
NCT06775730 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06775730 about?
NCT06775730 is a clinical study titled "A Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants". The purpose of this study is to examine the potential for drug-drug interactions.
What is the current status of trial NCT06775730?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2024-12-30. Estimated completion is 2025-04-03.
What conditions does trial NCT06775730 study?
This clinical trial studies the following conditions: Healthy Adult Female Participants.
What interventions are being tested in trial NCT06775730?
The interventions under investigation include: Ensitrelvir (DRUG).
Who is sponsoring clinical trial NCT06775730?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06775730 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adult Female Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.